Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy

Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy

Cancer remains a major global health challenge. Traditional chemotherapy often results in side effects and drug resistance, necessitating the development of alternative treatment strategies such as gene therapy. Mesoporous silica nanoparticles (MSNs) offer many advantages as a gene delivery carrier,...

Full description

Bibliographic Details
Main Authors: Nisar Ul Khaliq, Juyeon Lee, Joohyeon Kim, Yejin Kim, Sohyeon Yu, Jisu Kim, Sangwoo Kim, Daekyung Sung, Hyungjun Kim
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceutics
Subjects:
mesoporous silica nanoparticles
biocompatibility
surface modification
gene delivery
co-delivery
cancer therapy
Online Access:https://www.mdpi.com/1999-4923/15/5/1432

Internet

https://www.mdpi.com/1999-4923/15/5/1432

Similar Items